Remiges Ventures is a biotech-focused venture capital firm that backs early-stage and growth opportunities in drug discovery and life sciences. The firm highlights its portfolio companies and strategic collaborations across therapeutic areas, including gene therapy and neurological and cancer indications, with activity and investments reportedly centered in the biopharma ecosystem. Through its RDiscovery Fund and related initiatives, Remiges aims to incubate and support breakthrough scientific ventures from discovery through clinical development, leveraging its deep domain expertise. The company maintains information and updates on its activities via its website, including news and team pages, and engages with the broader biotech community online.
No recent news for this company.